Undisclosed Discovery Programs

About Serna Bio

Serna Bio is an early-stage biotech at the forefront of RNA-targeted small molecule discovery, utilizing a proprietary AI-driven platform to explore RNA-small molecule interactions. The company's mission is to unlock a new class of therapeutics by targeting structured RNA elements, thereby addressing disease-causing proteins and pathways previously considered inaccessible. As a private, pre-revenue entity, it is positioned in the high-growth, high-potential field of RNA medicine beyond modalities like ASOs and siRNA. Its success hinges on validating its computational platform and translating its discoveries into a viable preclinical and clinical pipeline.

Therapeutic Areas